1
|
Korbmacher M, van der Meer D, Beck D, de Lange AMG, Eikefjord E, Lundervold A, Andreassen OA, Westlye LT, Maximov II. Brain asymmetries from mid- to late life and hemispheric brain age. Nat Commun 2024; 15:956. [PMID: 38302499 PMCID: PMC10834516 DOI: 10.1038/s41467-024-45282-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 01/19/2024] [Indexed: 02/03/2024] Open
Abstract
The human brain demonstrates structural and functional asymmetries which have implications for ageing and mental and neurological disease development. We used a set of magnetic resonance imaging (MRI) metrics derived from structural and diffusion MRI data in N=48,040 UK Biobank participants to evaluate age-related differences in brain asymmetry. Most regional grey and white matter metrics presented asymmetry, which were higher later in life. Informed by these results, we conducted hemispheric brain age (HBA) predictions from left/right multimodal MRI metrics. HBA was concordant to conventional brain age predictions, using metrics from both hemispheres, but offers a supplemental general marker of brain asymmetry when setting left/right HBA into relationship with each other. In contrast to WM brain asymmetries, left/right discrepancies in HBA are lower at higher ages. Our findings outline various sex-specific differences, particularly important for brain age estimates, and the value of further investigating the role of brain asymmetries in brain ageing and disease development.
Collapse
Affiliation(s)
- Max Korbmacher
- Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway.
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
- Mohn Medical Imaging and Visualization Centre (MMIV), Bergen, Norway.
| | - Dennis van der Meer
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway
- Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| | - Dani Beck
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- Department of Psychology, University of Oslo, Oslo, Norway
| | - Ann-Marie G de Lange
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway
- Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
- Department of Psychiatry, University of Oxford, Oxford, UK
| | - Eli Eikefjord
- Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway
- Mohn Medical Imaging and Visualization Centre (MMIV), Bergen, Norway
| | - Arvid Lundervold
- Mohn Medical Imaging and Visualization Centre (MMIV), Bergen, Norway
- Department of Biomedicine, University of Bergen, Bergen, Norway
| | - Ole A Andreassen
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway
- KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway
| | - Lars T Westlye
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway
- Department of Psychology, University of Oslo, Oslo, Norway
- KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway
| | - Ivan I Maximov
- Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway.
- NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
| |
Collapse
|
2
|
Wang M, Korbmacher M, Eikeland R, Craven AR, Specht K. The intra-individual reliability of 1 H-MRS measurement in the anterior cingulate cortex across 1 year. Hum Brain Mapp 2024; 45:e26531. [PMID: 37986643 PMCID: PMC10789202 DOI: 10.1002/hbm.26531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Revised: 10/03/2023] [Accepted: 10/23/2023] [Indexed: 11/22/2023] Open
Abstract
Magnetic resonance spectroscopy (MRS) is the primary method that can measure the levels of metabolites in the brain in vivo. To achieve its potential in clinical usage, the reliability of the measurement requires further articulation. Although there are many studies that investigate the reliability of gamma-aminobutyric acid (GABA), comparatively few studies have investigated the reliability of other brain metabolites, such as glutamate (Glu), N-acetyl-aspartate (NAA), creatine (Cr), phosphocreatine (PCr), or myo-inositol (mI), which all play a significant role in brain development and functions. In addition, previous studies which predominately used only two measurements (two data points) failed to provide the details of the time effect (e.g., time-of-day) on MRS measurement within subjects. Therefore, in this study, MRS data located in the anterior cingulate cortex (ACC) were repeatedly recorded across 1 year leading to at least 25 sessions for each subject with the aim of exploring the variability of other metabolites by using the index coefficient of variability (CV); the smaller the CV, the more reliable the measurements. We found that the metabolites of NAA, tNAA, and tCr showed the smallest CVs (between 1.43% and 4.90%), and the metabolites of Glu, Glx, mI, and tCho showed modest CVs (between 4.26% and 7.89%). Furthermore, we found that the concentration reference of the ratio to water results in smaller CVs compared to the ratio to tCr. In addition, we did not find any time-of-day effect on the MRS measurements. Collectively, the results of this study indicate that the MRS measurement is reasonably reliable in quantifying the levels of metabolites.
Collapse
Affiliation(s)
- Meng‐Yun Wang
- Department of Biological and Medical PsychologyUniversity of BergenBergenNorway
- Mohn Medical Imaging and Visualization Centre (MMIV)Haukeland University HospitalBergenNorway
| | - Max Korbmacher
- Mohn Medical Imaging and Visualization Centre (MMIV)Haukeland University HospitalBergenNorway
- Department of Health and FunctioningWestern Norway University of Applied SciencesBergenNorway
- NORMENT Centre for Psychosis Research, Division of Mental Health and AddictionUniversity of Oslo and Oslo University HospitalOsloNorway
| | - Rune Eikeland
- Department of Biological and Medical PsychologyUniversity of BergenBergenNorway
- Mohn Medical Imaging and Visualization Centre (MMIV)Haukeland University HospitalBergenNorway
| | - Alexander R. Craven
- Department of Biological and Medical PsychologyUniversity of BergenBergenNorway
- Department of Clinical EngineeringHaukeland University HospitalBergenNorway
| | - Karsten Specht
- Department of Biological and Medical PsychologyUniversity of BergenBergenNorway
- Mohn Medical Imaging and Visualization Centre (MMIV)Haukeland University HospitalBergenNorway
- Department of EducationUiT The Arctic University of NorwayTromsøNorway
| |
Collapse
|